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Insulin-dependent diabetes mellitus (IDDM) is a polygenic disease caused by progressive autoimmune infiltration
(insulitis) of the pancreatic islets of Langerhan, culminating in the destruction of insulin-producing b cells. Genome
scans of families with diabetes suggest that multiple loci make incremental contributions to disease susceptibility.
However, only the IDDM1 locus is well characterized, at a molecular and functional level, as alleleic variants of
the major histocompatibility complex (MHC) class II HLA-DQB1, DRB1, and DPB1 genes that mediate antigen
presentation to T cells. In the nonobese diabetic (NOD) mouse model, the Idd1 locus was shown to be the
orthologous MHC gene I-Ab. Inheritance of susceptibility alleles at IDDM1/Idd1 is insufficient for disease devel-
opment in humans and NODmice. However, the identities and functions of the remaining diabetes loci (Idd2–Idd19
in NOD mice) are largely undefined. A crucial limitation in previous genetic linkage studies of this disease has been
reliance on a single complex phenotype—diabetes that displays low penetrance and is of limited utility for high-
resolution genetic mapping. Using the NOD model, we have identified an early step in diabetes pathogenesis that
behaves as a highly penetrant trait. We report that NOD-derived alleles at both the Idd5 and Idd13 loci regulate
a T lymphocyte–dependent progression from a benign to a destructive stage of insulitis. Human chromosomal
regions orthologous to the Idd5 and -13 intervals are also linked to diabetes risk, suggesting that conserved genes
encoded at these loci are central regulators of disease pathogenesis. These data are the first to reveal a role for
individual non-MHC Idd loci in a specific, critical step in diabetes pathogenesis—T cell recruitment to islet lesions
driving destructive inflammation. Importantly, identification of intermediate phenotypes in complex disease path-
ogenesis provides the tools required to progress toward gene identification at these loci.
Introduction
Type 1 or insulin-dependent diabetes mellitus (IDDM)
is a complex trait that is conferred by allelic variation
at multiple loci. However, efforts to define the genetics
of common polygenic disorders have been hampered by
the low penetrance of individual loci, and IDDM is an
intensively studied example. Genetic analyses of families
with IDDM have generated discrepancies likely reflect-
ing variability among study populations, which limits
consensus on disease linkage to only a few loci (Con-
cannon et al. 1998; Mein et al. 1998). Genetic dissection
of IDDM has been enabled by the nonobese diabetic
(NOD)mouse model (Makino et al. 1980), which closely
recapitulates the human disease. Nineteen Idd suscep-
tibility loci have been identified in the NOD mouse, and
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human-genome scans reveal similarly complex inheri-
tance (Davies et al. 1994; Concannon et al. 1998) in
mice (Makino et al. 1980; Ikegami et al. 1995; McAleer
et al. 1995; Wicker et al. 1995; Vyse and Todd 1996;
Podolin et al. 1997, 1998). The major diabetes-suscep-
tibility locus, IDDM1 in humans (MIM 222100) and
Idd1 in mice, maps to variation in the major histocom-
patibility complex (MHC) class II genes. The remarkable
sequence similarity between human HLA-DQB1 and
mouse H-2 I-AB susceptibility alleles lies in residues cru-
cial for antigen presentation to T cells (Hattori et al.
1986; Acha-Orbea and McDevitt 1987; Todd et al.
1987). However, the molecular basis of MHC-linked
diabetes susceptibility is more complex than was origi-
nally appreciated. For example, different HLA-DQB al-
leles are associated with diabetes risk in distinct popu-
lations, and evidence for association of both DRB1
(Sheehy et al. 1989) and DPB1 alleles has been reported
elsewhere (Erlich et al. 1996; Noble et al. 1996a, 1996b,
2000). Beyond the critical role of class II alleles, evidence
for linkage to extended MHC haplotypes includes var-
iants in the peptide transporter genes in some human
populations (Caillat-Zucman et al. 1995; Deng et al.
1995). In the NOD mouse, recent data support at least
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two additional diabetes-associated genes in the MHC
region near the transporter gene Lmp2 (Hattori et al.
1999). Thus, MHC markers are unique in displaying
strong linkage to the diabetes phenotype in humans and
mice, but a susceptible MHC haplotype alone is insuf-
ficient to confer disease.
In marked contrast to the strong effects of MHC hap-
lotype, whole-genome scans in NOD mice (Cordell and
Todd 1995) and in humans (Davies et al. 1994; Con-
cannon et al. 1998; Mein et al. 1998) suggest that many
non-MHC Idd loci make incremental contributions to
disease susceptibility. Only two human loci outside the
MHC have been clearly established in independent stud-
ies. IDDM2 on chromosome 11p15 maps to a VNTR
sequence upstream of the insulin gene (Bennett et al.
1995) and has been suggested to affect insulin expres-
sion and T cell tolerance to the protein (Bennett and
Todd 1996; Vafiadis et al. 1997). A region on human
chromosome 2q has been linked to IDDM, by several
groups (Davies et al. 1994; Copeman et al. 1995; Ow-
erbach and Gabbay 1995; Morahan et al. 1996; Es-
posito et al. 1998; Mein et al. 1998) and is syntenic to
the Idd5 locus on mouse chromosome 1 (Todd et al.
1991; Ghosh et al. 1993; Garchon et al. 1994; Cordell
and Todd 1995; Cordell et al. 1998). However, iden-
tification of non-MHC susceptibility genes in humans
and mice has been difficult, and neither the identities
nor the pathogenic contributions of most of the re-
maining loci are known.
Previous efforts to map diabetes-susceptibility genes
in humans and rodents share a crucial limitation—the
reliance on a single complex phenotype, diabetes. Since
this clinical endpoint reflects the actions of many genes
acting in complex pathways, it is not surprising that the
influence of single loci is hard to resolve. We reasoned
that the identification of intermediate (preclinical) di-
abetes phenotypes in islet inflammation might better
reflect the action of one or a subset of essential genes
common to IDDM-susceptible humans and rodents.
One such phenotype was provided by identification of
a pivotal early step in the islet inflammatory process.
Infiltration of the pancreatic islets of Langerhans by
T cells and antigen-presenting cells (APCs) is a pro-
tracted process that precedes overt diabetes by months
to years (Hanninen et al. 1992; Itoh et al. 1993). Infil-
tration begins as a leukocyte accumulation around the
islet perimeter (peri-insulitis), which then invades the
islet interior (invasive insulitis), ultimately resulting in
diabetes in 70%–90% of female NOD mice by age 6
mo (Signore et al. 1989; Castano and Eisenbarth 1990;
Jarpe et al. 1991; Waters et al. 1992; Jansen et al. 1994;
Signore et al. 1994; Fox and Danska 1997). T cells are
critical for invasive insulitis, since protracted peri-in-
sulitis occurs in NOD mice depleted of T cells by ad-
ministration of antibodies directed against T cell surface
markers (Charlton et al. 1988; Sempe et al. 1991; Cha-
tenoud et al. 1994, 1997). Considerable evidence in-
dicates that destruction of islet b cells is also T
cell–dependent (reviewed in Toyoda and Formby 1998).
Although T cell function is clearly central to destructive
islet inflammation, the Idd loci that control this aspect
of autoimmune pathogenesis remain undefined.
A clue to the genetic control of T cell pathogenesis
was provided by our previous study, in which we com-
pared insulitis progression in both NOD and the non-
obese, diabetes-resistant (NOR) strain of mice (Fox and
Danska 1998). NOR is a recombinant inbred strain that
inherits 88% of the genome from NOD and the re-
maining 12% from the C57BLKS/J strain (Prochazka
et al. 1992). The NOR and NOD strains share the dia-
betogenic MHC haplotype H-2g7 (Idd1) but differ at 5
of the remaining 18 Idd loci (Prochazka et al. 1992;
Serreze et al. 1994). Thus, the inheritance of C57BLKS/
J-derived alleles at Idd4, -5, -9, -11, and -13 is sufficient
to protect NOR from IDDM. We found that NOR di-
abetes resistance correlated with a protracted peri-in-
sulitis involving minimal T cell contribution (Fox and
Danska 1998). Thus, transition from peri- to invasive
insulitis appeared to be dependent on T cell infiltration
and the Idd loci that are allelically variable between
NOR and NOD mice. Importantly, these results impli-
cated distinct genetic control of different immune-cell
types in early islet inflammation. Here, we have inves-
tigated the genetic control of this step in diabetes de-
velopment by performing a linkage analysis in
(NOD#NOR) F2 progeny. Progression from peri- to
invasive insulitis behaved as a highly penetrant trait
controlled by an interaction between 2 of the 19 Idd
loci, Idd5 and -13. Remarkably, chromosomal regions
syntenic to Idd5 and -13 are the only known non-MHC
diabetes-susceptibility loci that are shared by humans
and mice. Our data reveal for the first time that these
two loci regulate a critical early step in diabetes path-
ogenesis, orchestrated through T cell recruitment to nas-
cent autoimmune islet lesions.
Material and Methods
Mice
All mice used in these studies were maintained in a
barrier facility at the Hospital for Sick Children (To-
ronto). In our colony, diabetes incidence at age 6 mo in
NOD animals is 83% in females, 9% in males, and 0
in NOR and (NOD#NOR) F1 mice.
Immunohistochemistry
Pancreata were removed from 80-d-old NOD and
NOR (NOD#NOR) F1 female mice and from
(NOD#NOR) F2 intercross male and female mice, were
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immersed in TissueTec (Bayer Labs), snap-frozen in liq-
uid nitrogen, and stored at70 C. Preparation of serial
frozen sections was performed with a Leica CM 3050
Cryostat (Leica Canada). To maximize analysis of in-
dependent islet infiltrates, serial 5-mm sections were pre-
pared from each of three depths of the 5-mm-thick tissue
block, in which each series of sections examined was
sampled at intervals of 300 mm apart, as described
elsewhere (Fox and Danska 1998). Previous morpho-
metric studies demonstrate that 2–3-mo-old mice have
islets averaging 100 mm in diameter and that each pan-
creas contains ∼1,000 islets (Bonnevie-Nielsen et al.
1983). Pancreatic sections were stained with Mayer’s
hematoxylin and eosin Y (HE; Sigma), to visualize
leukocyte infiltration. For immunohistochemical analy-
sis, serial sections were then incubated with biotin–anti-
CD3 (145-2C11; [Leo et al. 1987]) or biotin–anti-MHC
class II (10.2-16 [Oi et al. 1978]) antibodies and
ExtrAvidin-Horseradish peroxidase (Sigma). Antibody
staining was visualized with AEC substrate (Sigma). An-
tibodies were prepared by protein G purification from
tissue-culture supernatants and were biotin conjugated
(Cedarlane Labs), as described elsewhere (Fox and Dan-
ska 1997). Insulitis severity was scored in HE–stained
pancreatic sections. Approximately 250 islets from three
different tissue depths 1300 mm apart were examined in
each animal and were graded by assignment of the fol-
lowing scores: 0, no visible infiltrates; 1, peri-insulitis,
indicated by perivascular and peri-islet infiltrates; 2,
!50% of the islets displaying invasive infiltrates (defined
as islet interior occluded by leukocytes); 3, 150% of the
islets displaying invasive insulitis when !50% of the islet
is occluded by leukocytes; or 4, complete infiltration,
virtually all islets displaying invasive insulitis of
50%–100% of the islet. This approach and scoring sys-
tem has been used extensively for analysis of autoim-
mune insulitis, by many laboratories (Wicker et al. 1987,
1992; Stein et al. 1992; Yui et al. 1996).
Genomic DNA Preparation
Splenic DNA from C57BLKS/J mice was purchased
from the Jackson Labs DNA Resource (Jackson Labo-
ratory). Genomic DNAwas also prepared from tail snips
of 30 d-old DBA/2J, C57BL/6J, NOD, NOR
(NOD#NOR) F1, and (NOD#NOR) F2 intercross
mice, by standard methods. Each preparation was di-
luted 1:100 for use in PCR amplification.
Genotyping
Genotyping of NOR and (NOD#NOR) F2 inter-
cross progeny was performed using microsatellite
markers (Whitehead Institute for Biomedical Research/
MIT Center for Genome Research). PCR primer pairs
were obtained from Research Genetics. (NOD#NOR)
F2 intercross animals were typed for microsatellite al-
leles at Idd4 (D11Mit30 and D11Mit320), Idd5
(D1Mit3, D1Mit8, D1Mit24, D1Mit46, D1Mit77, and
D1Mit122), Idd9/11 (D4Mit13, D4Mit16, and
D4Mit72), and Idd13 (D2Mit17, D2Mit135,
D2Mit338, D2Mit395, D2Mit411, D2Mit423, and
D2Mit490). These mice were also typed at C57BLBKS-
derived regions in the NOR genome that do not contain
known Idd loci on chromosomes 7 (D7Mit105), 12
(D12Mit230), and 18 (D18Mit4 and D18Mit197).
NOR mice were typed for NOD-, DBA/2J- or C57BL/
6J-derived alleles at multiple markers on chromosome
1 (D1Mit3, D1Mit8, D1Mit11, D1Mit18, D1Mit22,
D1Mit24, D1Mit46, D1Mit48, D1Mit65, D1Mit66,
D1Mit72, D1Mit77, D1Mit122, D1Mit178,
D1Mit212, D1Mit213, D1Mit231, D1Mit245,
D1Mit279, D1Mit305, D1Mit306, D1Mit322,
D1Mit383, D1Mit411, D1Mit414, and D1Mit430)
and chromosome 2 (D2Mit17, D2Mit22, D2Mit62,
D2Mit135, D2Mit144, D2Mit147, D2Mit206,
D2Mit229, D2Mit256, D2Mit333, D2Mit338,
D2Mit343, D2Mit393, D2Mit395, D2Mit411,
D2Mit423, D2Mit447, D2Mit452, D2Mit480,
D2Mit490, and D2Mit493). The order of these mark-
ers derives from the Whitehead Institute for Biomedical
Research/MIT Center for Genome Research. For most
primer pairs, 30 ng of genomic DNA was amplified for
35–40 cycles, with the following conditions: 30 s at
94C, 30 s at 55C, and 1 min at 72C. For D11Mit30,
D4Mit11, D12Mit51, and D18Mit21, PCR amplifi-
cation was performed with 30 ng of genomic DNA for
40 cycles (30 s at 94C, 40 s at 50C, and 1 min 10 s
at 72C in 2.5 mM MgCl2). The PCR amplification
products were electrophoresed through 2% NuSieve
(American Bioanalytical) and 2% agarose (Gibco BRL)
gels and were visualized with ethidium bromide.
Statistical Analysis
Quantitative-trait linkage analysis was performed as
follows: a genetic map was built on the basis of the
Whitehead Institute for Biomedical Research/MIT Cen-
ter for Genome Research and EUCIB (UK Human Ge-
nome Project Mapping Center) marker orders, and
markers were analyzed for trait linkage, by the MAP-
MAKER EXP v3.0 and QTL v1.1 suite of programs
(Lander et al. 1987; Genome Center Software Infor-
mation and Documentation). Multipoint analysis was
conducted using recessive, dominant, and additive mod-
els. Linkage to chromosome 1 (Idd5) was maximal un-
der an additive model, and linkage to chromosome 2
(Idd13) was maximal under a dominant model (see the
Results section). The LOD scores, proportion of the trait
variance explained, and 1-LOD confidence intervals of
the position of the peaks were determined for all animals
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and separately for females and males. Haplotype con-
struction was performed, to detect close double recom-
binants, and microsatellite typing was reexamined, to
correct any errors. For chromosome 2 markers, several
mice still typed as close double recombinants and were
excluded from the study. Furthermore, since the marker
order on chromosome 2 differs markedly between dif-
ferent reference maps, we also analyzed chromosome 2
by using pairwise linkage.
Results
T Cell Dependence of Transition from Peri- to Invasive
Insulitis
To determine whether progression from peri- to in-
vasive insulitis was invariably associated with T cell in-
filtration, we analyzed T cell and APCs presence in serial
pancreatic sections of 80-d-old NOD, NOR,
(NOD#NOR) F1, and (NOD#NOR) F2 intercross
mice. Invasive insulitis in NOD and (NOD#NOR) F1
animals (fig. 1A, panels a and b) was characterized by
coincident infiltration of MHC class II APCs (fig. 1A,
panels d and e) and CD3 T cells (fig. 1A, panels g and
h). In contrast, only mild peri-insulitis was seen in NOR
mice (fig. 1A, panel c). Although robust MHC class II
staining was evident in NOR peri-islet infiltrates (fig.
1A, panel f), few or no CD3-expressing T cells were
observed in these lesions (fig. 1A, panel i), a result con-
cordant with our previous study (Fox and Danska
1998). In (NOD#NOR) F2 intercross progeny ( ),n = 19
both the NOD and NOR parental phenotypes were ob-
served. Progression to invasive insulitis (fig. 1B, panel
a) was associated with islet infiltration by APCs and T
cells (fig. 1B, panels c and e, respectively). In contrast,
other (NOD#NOR) F2 mice displayed peri-insulitis (fig.
1B, panel b) characterized by MHC class II APCs in
the absence of CD3 T cells (fig. 1B, panels d and f,
respectively). These results suggested that the transition
from peri- to invasive insulitis depends on T cell re-
cruitment and is regulated by loci that are allelically
variable between NOD and NOR mice.
Next, we examined whether the progression from
peri- to invasive insulitis behaved as a preclinical trait
suitable for genetic linkage analysis. Insulitis severitywas
measured in 82 male and female (NOD#NOR) F2 prog-
eny at age 80 d. Two distinct phenotypes were evident
in the F2 animals: 39% had invasive insulitis (insulitis
score 1.5) and 61% had mild peri-insulitis (insulitis
score 0.3), a result characteristic of a bimodal trait
(fig. 2). Sex dimorphism is well established in NOD di-
abetes, in which disease incidence is higher in female,
compared with male, mice (Makino et al. 1980; Pozzilli
et al. 1993). In 80-d-old (NOD#NOR) F2 animals, only
a marginal increase in insulitis severity was observed in
female, compared with age-matched male, mice (fig. 2;
Mann-Whitney test for significance, , ).U = 590 P = .03
We previously used quantitative reverse transcrip-
tase–coupled PCR to examine inflammatory progression
in purified male and female NOD islets. At age 30 d, T
cell cytokine profiles in islet lesions were already biased
toward T helper 1 in females and T helper 2 in males.
Sex differences in the abundance of T cells and APCs
were not evident until age 70 d (Fox and Danska 1997).
Examination of the insulitis phenotype at age 80 d in
the current study focused on an early stage in autoim-
mune disease progression, a stage prior to the appear-
ance of substantial differences in severity of male and
female islet inflammation.
NOD-Derived Alleles at Idd5 and Idd13 Control
Invasive Insulitis
All (NOD#NOR) F2 intercross progeny were geno-
typed for NOD- or BKS-derived alleles at microsatellite
markers spanning the Idd4, -5, -9/11, and -13 loci and
at markers in C57BLKS/J-derived regions of the NOR
genome that lacked previously identified Idd loci. Pair-
wise (table 1) and multipoint (fig. 3) statistical analyses
of the insulitis-severity scores and genotypes revealed
significant linkage (Lander and Kruglyak 1995) of in-
vasive insulitis to markers of Idd5 on chromosome 1
and Idd13 on chromosome 2. LOD scores were calcu-
lated separately for males and females, as well as for all
the (NOD#NOR) F2 animals. A significant LOD score
for all animals was observed at the marker D1Mit305
(LOD, 5.7; fig. 3A) when an additive model was used,
with the females displaying strong linkage (LOD, 5.3)
whereas the males produced virtually no linkage across
this region when the same model was used (LOD, !1.0).
We also observed significant linkage to a second locus
with maximal linkage at the marker D2Mit395, with
LOD scores of 5.7 for all animals, 4.0 for females, and
1.7 for males, under the assumption of a dominant
model (fig. 3B and table 1). In contrast, all othermarkers
examined in regions of allelic variation between the
NOD and NOR strains did not show significant linkage
(LOD, 2.6; data not shown). D1Mit305 and
D2Mit395 accounted for 31% and 27%, respectively,
of the genetic variation in insulitis phenotype and gen-
erated scores 2 log greater than the benchmark defined
for significant linkage (Lander and Kruglyak 1995).
These findings suggest that NOD-derived alleles at
both Idd5 and Idd13 drive invasive insulitis, providing
evidence of a genetic interaction controlling this phe-
notype (Frankel and Schork 1996). To analyze this in-
teraction, we compared the degree of insulitis in
(NOD#NOR) F2 progeny with all possible combina-
tions of NOD and NOR alleles at the two loci (fig. 4).
Clearly, homozygosity for BKS-derived alleles at either
Figure 1 Invasive insulitis is T cell dependent. A, Serial pancreatic cross-sections from 80-d-old female NOD, (NOD#NOR) F1, and
NOR mice were stained with HE, to visualize infiltrating cells (panels a–c); with the anti-MHC class II antibody 10.2-16, to visualize APC
(panels d–f); and with the anti-CD3e antibody 145-2C11, to visualize T cells (panels g–i). Panels d–iwere counterstained inMayer’s hematoxylin.
B, Serial sections from two representative (NOD#NOR) F2 intercross progeny were stained with HE (panels a and b), anti-MHC class II
(panels c and d), and anti-CD3 (panels e and f). Positive protein expression is indicated by dark brown coloration. Original magnification,
#250.
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Figure 2 Insulitis severity in (NOD#NOR) F2 intercross prog-
eny. The average insulitis severity was calculated in 82 80-d-old
(NOD#NOR) F2 intercross mice by the scoring of HE–stained pan-
creatic cross-sections. As shown, a scatter plot comparing individual
insulitis severity in male (blackened circles) and female (unblackened
circles) animals clearly indicates that insulitis severity behaves as a
bimodal trait.
Table 1
Pairwise Linkage Analysis of Chromosome 2
MARKER
%
VARIANCE
LOD
SCORE
POSITION
MIT JAX
D2Mit395 26.9 5.3 55.7 66.9
D2Mit17 16.4 3.1 56.8 69.0
D2Mit338 23.3 4.5 59.0 57.5
D2Mit135 20.2 3.9 61.2 73.0
D2Mit490 19.7 3.8 64.5 64.5
D2Mit423 14.3 2.7 68.9 68.9
D2Mit411 7.9 1.4 77.6 77.6
NOTE.—The (NOD#NOR) F2 data for markers
of chromosome 2 were also analyzed by pairwise
linkage analysis. The marker name, percentage of
variance, and LOD score are shown. As is also
shown, the relative order of these markers differs
according to information available at the White-
head Institute for Biomedical Research/MITCenter
for Genome Research (MIT) and the Jackson Lab-
oratory (JAX). For both databases, the position of
each marker from the centromere of chromosome
2 is shown in centimorgans.
Idd5 (D1Mit305) or Idd13 (D2Mit395) conferred po-
tent resistance to invasive insulitis; all animals of these
genotypes displayed insulitis scores !0.3 (fig. 4). The
powerful role of NOD alleles at these two loci was also
evident in this study. Insulitis progression (severity score
11.0) was observed only in the (NOD#NOR) F2 ani-
mals that carried at least one NOD-derived allele at both
Idd5 and Idd13 (fig. 4). (NOD#NOR) F2 mice carrying
NOD alleles at Idd5 and Idd13 provided evidence for
the penetrance of the insulitis-progression phenotype.
Seventy-four percent (32/43) of F2 animals carrying at
least one NOD-derived allele at both Idd5 and Idd13
displayed insulitis scores 11.0. Evidence for genetic in-
teraction between Idd5 and Idd13 is provided by com-
parison of insulitis values of mice with at least one NOD
allele at each locus ( ) to the other animals (n = 38 n =
). Using a t test for nonequal variances in the two44
groups yielded , 44 df; two-tailed .t = 9.3 P ! .0001
Thus, a genetic interaction between NOD-derived alleles
at the Idd5 and Idd13 loci promotes the transition from
peri- to invasive insulitis, an obligate step in early islet
inflammation. The effect could be blocked by homo-
zygosity for BKS-derived resistance alleles at either locus.
Interestingly, although the phenotype distributions were
very similar between male and female (NOD#NOR) F2
progeny (fig. 2), males contributed little to the Idd5 link-
age (fig. 3). This observation likely reflects the relatively
small numbers of animals with each of the nine possible
Idd5 and Idd13 genotype combinations when they are
subdivided by sex (fig. 4).
Idd5 and Idd13 Regulate T Cell Influx into Islet Lesions
Progression to invasive insulitis was associated with
T cell invasion of islet lesions (fig. 1A and B), suggesting
that the two features are controlled by the same loci.
We used immunohistochemistry to examine T cells and
APCs in 19 randomly selected (NOD#NOR) F2 inter-
cross mice. Eight of these animals (3 male and 5 female)
had inherited at least one NOD-derived allele at Idd5
and Idd13; all displayed invasive insulitis (severity scores
1.2–2.0), and 98% of their affected islets showed T cell
infiltration (table 2, top). In contrast, 11 animals (2 male
and 9 female) were homozygous for BKS-derived alleles
at either or both of the Idd5 and Idd13 loci; all of these
mice displayed mild peri-insulitis (severity scores
0.08–0.23), and T cells were observed in only 4.8% of
the islet lesions scored in these animals (table 2, bottom).
Strikingly, these results suggest that the mechanism by
which Idd5 and Idd13 drive insulitis progression is T
cell recruitment to, or retention in, islet lesions.
Genetic Maps of NOR Chromosomes 1 and 2
Progress toward the identification of the genes at
Idd5 and Idd13 depends on high-resolution genetic
mapping. NOR is a recombinant inbred strain pro-
viding an opportunity to define the C57BLKS/J-de-
rived segments, of chromosomes 1 and 2, in which
the genes regulating insulitis progression reside. The
C57BLKS/J strain was derived from two parental
strains, C57BL/6J (B6) and DBA/2J (Naggert et al.
1995). Consequently, NORmice harbor chromosomal
segments of NOD, DBA/2J, and B6 origin. To refine
the boundaries of the NOR chromosome 1 and 2 seg-
ments that were of NOD, DBA/2J or B6 origin, NOR
mice were typed with microsatellite markers, and
these markers were ordered according to current ge-
netic maps (see the Materials and Methods section).
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Figure 3 NOD-derived alleles at Idd5 and Idd13 confer invasive
insulitis. The LOD scores for the linkage of invasive insulitis in females,
males, and all animals are shown vs. the distance in centimorgans from
the centromeres of A, chromosome 1 and B, chromosome 2. The
relative order of the microsatellite markers along each chromosome
(according to Whitehead Institute for Biomedical Research/MIT Cen-
ter for Genome Research) is shown beneath the x axis of each graph.
C57BL/6J-derived regions (checkered boxes) are shown onNOR chro-
mosomes 1 and 2. The remaining regions (unblackened boxes) are
NOD-derived. *(NOD#NOR) F2 intercross animals could not be
scored for linkage telomeric to D1Mit305 or centromeric toD2Mit395
since these markers very close to the boundaries of these C57BL/6J-
derived chromosome segments in NOR mice.
Figure 4 Histogram scatter plots of the insulitis severity in male
(blackened circles) and female (unblackened circles) (NOD#NOR) F2
intercross progeny distributed by combination of NOD (N) and
C57BKS/J (B) alleles at Idd5 (D1Mit305) and Idd13 (D2Mit395).
Using 25 microsatellite markers on chromosome 1,
two B6-derived segments—one of 16 cM and another
of 21 cM in length, located between the D1Mit66 and
D1Mit322 loci and between the D1Mit178 and
D1Mit84 loci, respectively—were resolved in NOR
(fig. 5A). Control of invasive insulitis was most closely
linked to D1Mit305, near the telomeric boundary of
the latter segment (fig. 3). Analysis of 22 microsatellite
markers on chromosome 2 showed that NOR mice
contained a 25-cM B6-derived segment extending be-
tween D2Mit62 and D2Mit144 (fig. 5B). On chro-
mosome 2, maximal linkage of T cell–dependent in-
vasive insulitis was observed at D2Mit395, near the
centromeric boundary of the B6-derived segment (fig.
3 and 5B). As mentioned in the context of multipoint
linkage analysis, there is not yet a clear consensus on
the order of some chromosome 2 markers. On the
basis of these marker positions and the linkage anal-
ysis, we computed a 5-cM 1-LOD confidence interval
for Idd5 on chromosome 1 (fig. 5A) and a 4-cM 1-
LOD confidence interval for Idd13 on chromosome 2
(fig. 5B).
Discussion
Studies in humans, NOD mice, and BioBreeding (BB)
rats have demonstrated that the generation and function
of islet-reactive T cells depends on MHC haplotype
(Colle et al. 1981; Hattori et al. 1986; Todd et al. 1987;
Wicker et al. 1987). Clearly, b islet–cell destruction re-
quires the coinheritance of multiple susceptibility loci
(reviewed in Cordell and Todd 1995). Unraveling how
and when non-MHC Idd genes regulate IDDM patho-
genesis is key to the development of therapies to mod-
ulate disease progression in individuals at high-risk. The
success of identification of MHC class II as a major
diabetes gene, as well as the remarkable sequence sim-
ilarity between human DQb and mouse I-Ab suscepti-
bility alleles, established a precedent that will not be
easily fulfilled by other Idd genes. Unlike the high dia-
betes risk conferred by MHC class II alleles, it has been
suggested that non-MHC genes contribute a small, in-
cremental influence on disease susceptibility. Whole-ge-
nome scans in humans and in mice (Cordell and Todd
1995) have supported this idea, although the former
have yielded disparate results in different study popu-
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Table 2
T Cell Infiltration of (NOD#NOR) F2 Islets, Regulated by
Idd5 and Idd13
Idd5/Idd13
Insulitis
Severity
CD3Islets/
Total Islets Sex
NN/NN 1.30 15/15 Male
BN/NN 1.81 12/12 Female
NN/BN 1.87 9/11 Male
NN/BN 1.71 10/10 Female
NN/BN 1.62 21/21 Female
BN/BN 2.04 18/18 Female
BN/BN 1.82 18/18 Female
BN/BN 1.20 13/ 13 Male
Average or total 1.67 .29 116/118
BB/BB .09 1/5 Female
BB/BB .23 0/2 Female
BB/BB .08 0/4 Male
BN/BB .31 0/0 Female
BN/BB .11 0/5 Male
BN/BB .09 0/3 Female
BB/NN .12 0/2 Female
BB/NN .10 1/2 Female
BB/NN .13 0/3 Female
BB/BN .13 0/5 Female
BB/BN .12 0/4 Female
Average or total .14 .07 2/35
NOTE.—Frozen pancreatic sections were prepared from
19 (NOD#NOR) F2 intercross animals. Each animal was
typed as heterozygous (BN) or homozygous for NOD-de-
rived (NN) or C57BLKS/J-derived (BB) alleles at Idd5
(D1Mit305) and Idd13 (D2Mit395), and insulitis severity
was assessed. Serial frozen pancreatic sections were exam-
ined for the presence of CD3 T cells by immunohisto-
chemistry. Top, Eight (NOD#NOR) F2 mice displayed in-
vasive insulitis and T cell infiltration. Bottom, Eleven
(NOD#NOR) F2 mice displayed benign peri-insulitis and
minimal T cell infiltration. Mean insulitis severity SD in
each group is shown. The number of T cell–infiltrated islets
relative to the total number of islets examined is also shown.
lations (Concannon et al. 1998; Mein et al. 1998). To
gain greater insight into the genetic regulation of dia-
betes, it is critical to identify molecular and cellular
events in pathogenic islet inflammation and to link these
preclinical phenotypes to the genetic pathways that reg-
ulate IDDM susceptibility.
Previously, we defined an early step in disease path-
ogenesis, the transition from peri-insulitis, involving
APC migration, to T cell–dependent invasive insulitis,
which distinguishes NOD mice from the diabetes-resis-
tant NOR strain (Fox and Danska 1998). Here, we
report that NOD alleles at two loci, Idd5 and Idd13,
cooperatively regulate both the recruitment/retention of
T cells to islet lesions and the progression to invasive
insulitis. Importantly, the absence of a NOD-derived
allele at either locus results in complete resistance to
invasive insulitis, despite the presence of NOD alleles
at other known Idd loci, including the MHC (Idd1).
Consistent with our results, both male and female NOD
mice congenic for a BKS-derived chromosome 2 seg-
ment that includes the Idd13 interval defined here do
not display invasive insulitis (Serreze et al. 1998), and
(NOD#CBA) recombinant inbred animals homozy-
gous for CBA alleles on chromosome 1 or 2 are insulitis
resistant (Reifsnyder et al. 1999). Remarkably, human
and rat chromosomal regions orthologous to murine
Idd5 and -13 regions are the only identified non-MHC
loci that are also linked to IDDM susceptibility in hu-
mans and rats. Thus, the Idd5 and -13 loci are likely
to encode regulators of diabetes pathogenesis in all three
species. Although it remains to be determined in what
cell types (T cells, APCs, and/or islets) Idd5 and -13
exert their effects, our study provides a biological ra-
tionale to inform the search for candidate susceptibility
genes at these loci.
Idd5 in Diabetes Pathogenesis
Idd5 was originally identified as a chromosome 1 lo-
cus that affects the timing of peri-insulitis onset (Gar-
chon et al. 1991) and subsequently was shown to affect
both the kinetics and the severity of insulitis (Ghosh et
al. 1993). Multiple diabetes-susceptibility regions may
map within the 40-cM Idd5 interval (Yui et al. 1996;
Cordell et al. 1998). As displayed in table 3 and figure
5A, a chromosome segment containing murine Idd5 is
orthologous to four human diabetes-susceptibility
regions, including IDDM7 (Copeman et al. 1995; Es-
posito et al. 1998), IDDM12 (Owerbach and Gabbay
1995; Esposito et al. 1998), and IDDM13 (Morahan et
al. 1996; Esposito et al. 1998), all on chromosome 2q,
and IDDM6 on chromosome 18q (Merriman et al.
1997, 1998), as well as to the Iddm5 region of rat chro-
mosome 13 (Martin et al. 1999). In the data presented
here, T cell–dependent invasive insulitis maps to a 1-
LOD confidence interval near D1Mit305, a position that
likely excludes several candidate genes. Interleukin-1 re-
ceptor (Il1-r [Cornall et al. 1991; Garchon et al. 1991])
and the natural resistance–associated macrophage pro-
tein (Nramp-1) involved in the clearance of intracellular
pathogens (Govoni and Gros 1998) both map to regions
of chromosome 1 that are well outside the confidence
interval for the insulitis phenotype (fig. 4A). Further-
more, the high-resolution map of chromosome 1 indi-
cated that Bcl-2 and Ctla-4 are NOD-derived in the
NOR strain (fig. 4A), excluding them as candidates for
the T cell–dependent invasive insulitis phenotype. Bcl-2
was suggested as a candidate gene for the enhanced re-
sistance of NOD T cells to apoptosis after interleukin-
2 withdrawal (Garchon et al. 1994). Enhanced resistance
to cyclophosphamide-induced death by NOD compared
with B6 T cells was linked to a region of chromosome
1, and Ctla-4was suggested as a candidate gene (Colucci
et al. 1996, 1997). Allelic variants in Bcl-2 and Ctla-4
may contribute to diabetes susceptibility but apparently
are not responsible for the phenotype described here. A
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Figure 5 Chromosomes 1 and 2 in NOR mice. NOR genomic DNA was typed for NOD- (unblackened boxes) or C57BL/6J-derived
(checkered boxes) alleles at each microsatellite marker shown on chromosomes 1 (A) and 2 (B). The distance in centimorgans between markers
is shown to the far left. Several candidate genes that map to each region are also shown (in italics). * = 1-LOD confidence intervals were
calculated with MAPMAKER QTL. The gene locations and distances in centimorgans are adapted from published studies (Seldin 1996, 1997;
Siracusa et al. 1996, 1997), the Whitehead Institute for Biomedical Research/MIT Center for Genome Research, and the Jackson Laboratory.
The original location of Idd5 encompasses an interval 20–60 cM from the centromere of chromosome 1 (Cornall et al. 1991; Garchon et al.
1991). Idd13 was originally mapped to a 4-cM interval of chromosome 2 that spans the b2m, Il1, and Pcna genes (Serreze et al. 1994), within
which the 1-LOD confidence interval for insulitis progression resides.
number of genes without obvious links to diabetes path-
ogenesis map proximal to D1Mit305 (fig. 5A), including
those for the nicotinic acetylcholine receptor, Acrg
(Heidmann et al. 1986; Cohen-Haguenauer et al. 1989);
collagen type VI, Col6a3 (Schurr et al. 1990); retinal S-
antigen, Sag (Danciger et al. 1989); and the high-density
lipoprotein-binding protein, Hdlbp (Xia et al. 1993;
LeBoeuf et al. 1994). At Idd5, as at all other Idd regions,
the mapping of expressed sequence tags and defined cod-
ing regions is far from complete, so it remains likely that
these regions contain genes that have yet to be identified
and may include novel genes involved in diabetes
susceptibility.
Idd13 in Diabetes Pathogenesis
The second locus to which we mapped T cell–
dependent invasive insulitis is D2Mit395 in the Idd13
Table 3
Chromosomal Regions Orthologous to Murine Idd5 and Idd13 Contain Diabetes-Susceptibility Genes in the Rat and Human Genomes
MOUSE RAT HUMAN
Name
(Chromosome) Locations Phenotype (References)
Name
(Chromosome) Location (References) Name Location (References)
Idd5 (1) Bcl2- D1Nds1 Peri-insulitis (Garchon et al. 1991) Iddm5 (13) D13Mit1 diabetes progession (Martin
et al. 1999)
IDDM7 Chromosome 2q (Coperman et al.
1995; Esposito et al. 1998)
Idd5 (1) D1Nds4 Spontaneous and cyclophos-accelerated
diabetes (Cornall et al. 1991)
IDDM12 Chromosome 2q31 (Owerbach and
Gabby 1995; Esposito et al. 1998)
Idd5 (1) D1Mit5 Insulitis kinetics and severity (Ghosh et al. 1993),
insulitis susceptibility (Yui et al. 1996)
IDDM13 Chromosome 2q D2S164 (Morahan
et al. 1996; Esposito et al. 1998)
Idd5 (1) D1Mit4–Bcl2,
D1Mit5–Mit15,
D1Mit305
T cell recruitment and insulitis progression, inter-
action with Idd13 (present study)
IDDM6 Chromosome 18q21 (Merriman et
al. 1997, 1998)
Idd13 (2) D2Mit490–Mit144, H3a-
IL-1, IL-1-Pcna
IDDM (Serezze et al. 1998) Iddm6 (3) D3Mgh10, diabetes; D3Mit4, insulitis
severity, interaction with Iddm5
(Martin et al. 1999)
IDDM3 Chromosome 15q26 D15S107 (Field
et al. 1994; Zuberi et al. 1996)
Idd13 (2) D2Mit395 T cell recruitment and insulitis progression, inter-
action with Idd5 (present study)
NOTE.—Mouse, human, and rat homology maps (NCBI Human/Mouse Homology Relationships) establish that regions of the human and rat genomes previously found to be linked to type 1 diabetes risk, are
orthologous to the murine Idd5 and Idd13 intervals identified in this and prior studies of the NOD mouse. For Idd5 on chromsome 1, multiple diabetes-susceptibility regions were identified over a broad region of
human chromosome 2q and on human 18q. Interestingly, the region of the rat genome orthologous to murine Idd13 on chromosome 2 (55–60 cM), is Iddm6, which demonstrates genetic interaction with Iddm5 on
rat chromosome 13. The latter region is orthologous to murine chromosome 1 (56–62 cM) which overlaps the 1-LOD confidence interval for the Idd5 linkage to insulitis progression in this study.
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locus. Idd13 originally was mapped to a 4-cM region
of chromosome 2, flanked by the genes for beta-2-mi-
croglobulin (b2m) and proliferating-cell nuclear antigen
(Pcna; Serreze et al. 1994), although recent evidence sug-
gests that it is 30 cM in length (Serreze et al. 1998).
It is likely that the linkage reported here for the insulitis
progression lies within the previously published Idd13
interval (Serreze et al. 1998), although discrepancies be-
tween current chromosome 2 maps (Whitehead Institute
for Biomedical Research/MIT Center for Genome Re-
search, Jackson Laboratory [Siracusa et al. 1996, 1997])
remain to be clarified. Importantly, murine Idd13 is or-
thologous to the Iddm6 region of rat chromosome 3
(Martin et al. 1999) and may be orthologous to a human
chromosome 15 segment that contains the IDDM3 locus
(Field et al. 1994; Zamani et al. 1996), but there is some
disagreement on this point (Mein et al. 1998; table 3).
Of particular interest, insulitis severity in the BB rat
model was shown to be influenced by genetic interaction
between the Iddm6 locus and the Iddm5 locus (Martin
et al. 1999), a result consistent with our findings of
strong interaction between the syntenic murine Idd13
and Idd5 loci, respectively. In all three species, this chro-
mosome region includes b2m, a subunit of the MHC
class I complex. In multiple studies, allelic variation be-
tween NOD and NOR mice has been reported to affect
both the structure and the expression of MHC class I.
For example, the interval containing the NOD-derived
Idd13 encodes a b2m variant that affects an MHC class
I serological determinant (Serreze et al. 1998). In ad-
dition, interferon-g–mediated up-regulation of cell-sur-
face MHC expression is reportedly absent in cultured
NOD macrophages (Leiter and Serreze 1992), although
the Idd13 locus does not appear to control this effect
(Serreze et al. 1998). Allelic variation in the b2m se-
quence also exists between normal mouse strains (Mi-
chaelson 1983), so it remains unresolved how functional
variants in this protein may contribute to autoimmune
pathogenesis. Additional genes within the confidence in-
terval computed from our analysis include a cluster en-
coding minor histocompatibility antigens (Graff et al.
1994), recombinase A (Reca [Takahasi et al. 1994; Roca
and Cox 1997]), lymphocyte tyrosine kinase (Ltk [Sni-
jders et al. 1997]), and receptor tyrosine kinase (Tyro3
[Liao et al. 1996]) involved in bone resorption (Naka-
mura et al. 1998). The proinflammatory cytokine inter-
leukin-1 (Il1 [Siracusa et al. 1996, 1997]) also has been
considered a candidate gene for mouse Idd13 and for
human IDDM13 on chromosome 2q (Esposito et al.
1998). Considerable work remains to isolate and analyze
the function of gene(s), at the Idd13 and Idd5 loci, that
regulate the progression from benign to invasive
insulitis.
Conclusions
Rodent models of polygenic disease provide a unique
opportunity to coordinate genetic analyses with the
study of cellular pathogenesis. By comparing NOD and
NOR mice, we have identified a discrete step in insulitis
progression that is conferred by two susceptibility loci
and, by inference, two (sets of) genes that are common
to IDDM-susceptible humans and rodents. NOR mice
inherit genes from the NOD background that promote
the peri-islet and perivascular infiltration by APCs, the
earliest detectable stage in diabetes pathogenesis. How-
ever, this stage is apparently benign, since these lesions
contain few T cells (Fox and Danska 1998), and NOR
animals rarely progress to overt diabetes. Here we have
shown that NOD alleles at Idd5 and Idd13 together
regulate T cell influx into islet lesions, which is an ob-
ligate step in autoimmune pathogenesis and evident
months before overt disease onset. Our identification of
punctuated steps in the insulitis process suggested a
“simpler” preclinical phenotype that enabled genetic
linkage to two of many susceptibility loci and insight
into the cellular biology that these loci control. Genetic
analysis of other polygenic diseases underscores the util-
ity of this strategy. In (NZB#NZW) F1 mice, B cell
phenotypes that are markers of the autoimmune events
in systemic lupus erythematosus have greatly assisted in
the identification of susceptibility loci (Vyse et al. 1996;
Mohan et al. 1997). In type 2 diabetes, physiological
and genetic studies in rat models has allowed linkage of
multiple loci with specific facets of the disease, including
impaired insulin secretion, increased body-mass index,
and elevated blood-glucose levels (Galli et al. 1996; Gau-
guier et al. 1996). The genetic variants that confer di-
abetes risk in rats or mice may well differ from those in
humans, and, similarly, different constellations of genes
may mediate diabetes in genetically diverse human pop-
ulations. Although these genes may differ between spe-
cies and populations, they are likely to act on common
biological pathways that control islet inflammation and
b cell destruction. Importantly, the identification of ro-
dent genes within these shared pathways has promise
for resolving the molecular basis of diabetes pathogen-
esis, thereby illuminating targets for therapeutic inter-
vention in high-risk or newly diagnosed individuals.
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